[Cerebral embolic protection during transcatheter aortic valve replacement: analysis of data from PROTECTED-TAVR and future perspectives]
G Ital Cardiol (Rome)
.
2022 Dec;23(12 Suppl 2):38S-39S.
doi: 10.1714/3949.39292.
[Article in Italian]
Authors
Evelina Toscano
1
,
Ozan M Demir
2
,
Alessandro Beneduce
3
,
Arif Khokhar
4
,
Andrea Marrone
5
,
Jonathan Curio
6
,
Lars Sondergaard
7
,
Marco Toselli
8
Affiliations
1
U.O. Cardiologia Interventistica, Policlinico di Monza, Monza.
2
Department of Cardiology, St Thomas' Hospital, Londra, UK.
3
U.O. Cardiologia Interventistica, IRCCS San Raffaele, Milano.
4
Cardiology, Imperial College, Londra, UK.
5
Istituto Cardiovascolare, Azienda Ospedaliero-Universitaria di Ferrara, Cona (FE).
6
Department of Cardiology, Charité - Universitätsmedizin Berlin, Berlino, Germania.
7
The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenaghen, Danimarca.
8
U.O. Cardiologia Interventistica, Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA).
PMID:
36636875
DOI:
10.1714/3949.39292
No abstract available
MeSH terms
Aortic Valve / surgery
Aortic Valve Stenosis* / surgery
Embolic Protection Devices*
Humans
Prosthesis Design
Risk Factors
Transcatheter Aortic Valve Replacement* / adverse effects
Treatment Outcome